These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34332974)

  • 1. Effects of pramlintide on energy intake and food preference in rats given a choice diet.
    Kern KA; DiBrog AM; Przybysz JT; Mietlicki-Baase EG
    Physiol Behav; 2021 Oct; 240():113541. PubMed ID: 34332974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic pramlintide decreases feeding via a reduction in meal size in male rats.
    Kern KA; DiBrog AM; Kaur K; Przybysz JT; Mietlicki-Baase EG
    Peptides; 2024 Jun; 176():171197. PubMed ID: 38493922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats.
    Stein LM; McGrath LE; Lhamo R; Koch-Laskowski K; Fortin SM; Skarbaliene J; Baader-Pagler T; Just R; Hayes MR; Mietlicki-Baase EG
    Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R250-R259. PubMed ID: 34259025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha-7 nicotinic acetylcholine receptor agonist PHA-543613 reduces food intake in male rats.
    DiBrog AM; Kern KA; Demieri E; Mietlicki-Baase EG
    Pharmacol Biochem Behav; 2024 Apr; 237():173723. PubMed ID: 38331049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
    Smith SR; Blundell JE; Burns C; Ellero C; Schroeder BE; Kesty NC; Chen KS; Halseth AE; Lush CW; Weyer C
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E620-7. PubMed ID: 17505051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight.
    Mack C; Wilson J; Athanacio J; Reynolds J; Laugero K; Guss S; Vu C; Roth J; Parkes D
    Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1855-63. PubMed ID: 17855496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palatable food access impacts expression of amylin receptor components in the mesocorticolimbic system.
    Nashawi H; Gustafson TJ; Mietlicki-Baase EG
    Exp Physiol; 2020 Jun; 105(6):1012-1024. PubMed ID: 32306457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amylin-mediated control of glycemia, energy balance, and cognition.
    Mietlicki-Baase EG
    Physiol Behav; 2016 Aug; 162():130-40. PubMed ID: 26922873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
    Leinung MC; Grasso P
    Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent High-Fat Diet Intake Reduces Sensitivity to Intragastric Nutrient Infusion and Exogenous Amylin in Female Rats.
    Maske CB; Coiduras II; Ondriezek ZE; Terrill SJ; Williams DL
    Obesity (Silver Spring); 2020 May; 28(5):942-952. PubMed ID: 32237211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.
    Ravussin E; Smith SR; Mitchell JA; Shringarpure R; Shan K; Maier H; Koda JE; Weyer C
    Obesity (Silver Spring); 2009 Sep; 17(9):1736-43. PubMed ID: 19521351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss.
    Liberini CG; Koch-Laskowski K; Shaulson E; McGrath LE; Lipsky RK; Lhamo R; Ghidewon M; Ling T; Stein LM; Hayes MR
    Sci Rep; 2019 Jun; 9(1):8447. PubMed ID: 31186439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.
    Chapman I; Parker B; Doran S; Feinle-Bisset C; Wishart J; Strobel S; Wang Y; Burns C; Lush C; Weyer C; Horowitz M
    Diabetologia; 2005 May; 48(5):838-48. PubMed ID: 15843914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute ghrelin changes food preference from a high-fat diet to chow during binge-like eating in rodents.
    Bake T; Hellgren KT; Dickson SL
    J Neuroendocrinol; 2017 Apr; 29(4):. PubMed ID: 28219000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.
    Boyle CN; Rossier MM; Lutz TA
    Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
    Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
    Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects.
    Chapman I; Parker B; Doran S; Feinle-Bisset C; Wishart J; Lush CW; Chen K; Lacerte C; Burns C; McKay R; Weyer C; Horowitz M
    Obesity (Silver Spring); 2007 May; 15(5):1179-86. PubMed ID: 17495194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
    Singh-Franco D; Robles G; Gazze D
    Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin: a novel action in the brain to reduce body weight.
    Rushing PA; Hagan MM; Seeley RJ; Lutz TA; Woods SC
    Endocrinology; 2000 Feb; 141(2):850-3. PubMed ID: 10650969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat.
    Coccurello R; Romano A; Giacovazzo G; Tempesta B; Fiore M; Giudetti AM; Marrocco I; Altieri F; Moles A; Gaetani S
    Eur J Nutr; 2018 Jun; 57(4):1485-1498. PubMed ID: 28314964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.